Safe and successful treatment of refractory polyarteritis nodosa with tocilizumab in a patient with past hepatitis B virus infection: a case-based review
- 1 May 2021
- journal article
- review article
- Published by Springer Science and Business Media LLC in Clinical Rheumatology
- Vol. 40 (5), 2065-2070
- https://doi.org/10.1007/s10067-020-05345-4
Abstract
Polyarteritis nodosa is a primary systemic necrotizing vasculitis whose evolution follows, in many cases, a chronic remitting-recurrent course with refractoriness to conventional immunosuppressants. We report here the clinical case of a 75-year-old patient with serologies suggestive of past hepatitis B virus infection who presented a flare of polyarteritis nodosa with great secondary functional impairment. She had not responded to several previous immunosuppressants and required high doses of glucocorticoids to control the flare. After the initiation of biological therapy with tocilizumab, the patient experienced a rapid and marked clinical and analytical improvement, going into clinical remission and being able to remarkably lower the corticosteroid dose and stop the rest of the immunosuppressants. There was no evidence of hepatitis B virus reactivation or changes in the titers of any of the parameters related to the aforementioned infection. This clinical case represents the first case reported in the literature about the successful and safe treatment of polyarteritis nodosa with tocilizumab in a patient with serologies suggestive of past hepatitis B virus infection.This publication has 23 references indexed in Scilit:
- A case of refractory polyarteritis nodosa successfully treated with rituximabModern Rheumatology, 2015
- Long-term follow-up of a randomized trial on 118 patients with polyarteritis nodosa or microscopic polyangiitis without poor-prognosis factorsAutoimmunity Reviews, 2014
- AA amyloidosis in a polyarteritis nodosa patient treated with tocilizumabAmyloid, 2013
- 2012 Revised International Chapel Hill Consensus Conference Nomenclature of VasculitidesArthritis & Rheumatism, 2012
- Targeting Interleukin-6: All the Way to Treat Autoimmune and Inflammatory DiseasesInternational Journal of Biological Sciences, 2012
- Mycophenolate Mofetil vs Azathioprine for Remission Maintenance in Antineutrophil Cytoplasmic Antibody–Associated VasculitisJAMA, 2010
- Treatment of polyarteritis nodosa and microscopic polyangiitis without poor‐prognosis factors: A prospective randomized study of one hundred twenty‐four patientsArthritis & Rheumatism, 2010
- Azathioprine or Methotrexate Maintenance for ANCA-Associated VasculitisThe New England Journal of Medicine, 2008
- Prognostic Factors in Polyarteritis Nodosa and Churg-Strauss Syndrome A Prospective Study in 342 PatientsMedicine, 1996
- The American college of rheumatology 1990 criteria for the classification of polyarteritis nodosaArthritis & Rheumatism, 1990